Haemostasis is a series of steps your body takes to prevent bleeding. One of these steps is forming a blood clot. Blood clots protect us from excessive bleeding, but abnormal blood clotting can cause health problems. Thrombosis is when a blood clot forms in a part of the circulatory system. BHF has supported research into haemostasis since it was founded in 1961. We’ve awarded 1000 grants worth more than £150m in total.
Discovering new knowledge
BHF-funded research has led to better understanding of platelet biology, which means a better understanding of the mechanisms underlying clotting. BHF funding has also led to the discovery that most heart attacks are caused by thrombosis occurring in a coronary artery.
Developing new technology
Our researchers have developed technology which shines a new light on the mechanisms of haemostasis and thrombosis. This includes applying imaging techniques to watch blood clot formation in real-time.
Influencing clinical practice
We've supported several clinical trials which evaluate the safety of clot-busting drugs. These trials have influenced clinical guidelines.
Influencing policy
Research we've funded has continued to prove that smoking and air pollution affect how our blood works, leading to changes in policy.
Improving people’s lives
It’s estimated that 1 in 4 deaths worldwide are linked to blood clots. BHF-funded research has contributed to new prevention strategies and treatments which have helped patients at risk of dangerous blood clots.
Download the report with references and supplementary information
First published 7th February 2023